A peptide that successfully targeted and killed metastatic cancer cells in mice may open the door to developing more efficient ways to detect and treat metastatic breast cancer in humans, UTHealth Houston researchers have discovered. The research was published in Molecular Therapy Oncology and led by Mikhail Kolonin, Ph.D., director of the Center for Metabolic and Degenerative Diseases in The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases at McGovern Medical School at UTHealth Houston.
This article was originally published on MedicalXpress.com
